GSK 626616 is a YAK3/DYRK3 kinase inhibitor. It is a chemoprotective agent for the potential treatment of chemotherapy-induced anaemia.
For research use only. We do not sell to patients.
| Name | GSK-626616 |
|---|---|
| Iupac Chemical Name | (5Z)-2-(2,6-Dichloroanilino)-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolone |
| Synonyms | GSK-626616; GSK 626616; GSK626616. |
| Molecular Formula | C18H10Cl2N4OS |
| Molecular Weight | 401.27 |
| Smile | Clc1cccc(Cl)c1NC2=NC(=O)\C(=C\c3ccc4nccnc4c3)\S2 |
| InChiKey | RJPNRXFBYZVRIB-DHDCSXOGSA-N |
| InChi | InChI=1S/C18H10Cl2N4OS/c19-11-2-1-3-12(20)16(11)23-18-24-17(25)15(26-18)9-10-4-5-13-14(8-10)22-7-6-21-13/h1-9H,(H,23,24,25)/b15-9- |
| CAS Number | 1025821-33-3 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |